25 XP   0   0   10

GODAVARI DRUGS LTD.
Buy, Hold or Sell?

Let's analyse GODAVARI DRUGS LTD. together

PenkeI guess you are interested in GODAVARI DRUGS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GODAVARI DRUGS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about GODAVARI DRUGS LTD.

I send you an email if I find something interesting about GODAVARI DRUGS LTD..

Quick analysis of GODAVARI DRUGS LTD. (30 sec.)










What can you expect buying and holding a share of GODAVARI DRUGS LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
INR44.38
Expected worth in 1 year
INR64.48
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR20.11
Return On Investment
20.0%

For what price can you sell your share?

Current Price per Share
INR100.48
Expected price per share
INR90.00 - INR114.00
How sure are you?
50%

1. Valuation of GODAVARI DRUGS LTD. (5 min.)




Live pricePrice per Share (EOD)

INR100.48

Intrinsic Value Per Share

INR20.15 - INR126.73

Total Value Per Share

INR64.52 - INR171.11

2. Growth of GODAVARI DRUGS LTD. (5 min.)




Is GODAVARI DRUGS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$4m$3.5m$454.2k11.3%

How much money is GODAVARI DRUGS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$454.2k$629.4k-$175.1k-38.6%
Net Profit Margin2.4%3.3%--

How much money comes from the company's main activities?

3. Financial Health of GODAVARI DRUGS LTD. (5 min.)




What can you expect buying and holding a share of GODAVARI DRUGS LTD.? (5 min.)

Welcome investor! GODAVARI DRUGS LTD.'s management wants to use your money to grow the business. In return you get a share of GODAVARI DRUGS LTD..

What can you expect buying and holding a share of GODAVARI DRUGS LTD.?

First you should know what it really means to hold a share of GODAVARI DRUGS LTD.. And how you can make/lose money.

Speculation

The Price per Share of GODAVARI DRUGS LTD. is INR100.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of GODAVARI DRUGS LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in GODAVARI DRUGS LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR44.38. Based on the TTM, the Book Value Change Per Share is INR5.03 per quarter. Based on the YOY, the Book Value Change Per Share is INR6.97 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of GODAVARI DRUGS LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.060.1%0.060.1%0.080.1%0.050.1%0.040.0%
Usd Book Value Change Per Share0.060.1%0.060.1%0.080.1%0.050.1%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.060.1%0.060.1%0.080.1%0.050.1%0.040.0%
Usd Price Per Share0.91-0.91-0.78-0.53-0.47-
Price to Earnings Ratio15.07-15.07-9.39-10.21-13.30-
Price-to-Total Gains Ratio15.07-15.07-9.39-10.21-13.34-
Price to Book Ratio1.71-1.71-1.66-1.23-1.52-
Price-to-Total Gains Ratio15.07-15.07-9.39-10.21-13.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.20576
Number of shares829
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.060.05
Usd Total Gains Per Share0.060.05
Gains per Quarter (829 shares)50.0143.25
Gains per Year (829 shares)200.05172.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102001900173163
204003900346336
306005900519509
408007900692682
5010009900865855
6012001190010381028
7014001390012111201
8016001590013841374
9018001790015571547
10020001990017301720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%1.00.010.09.1%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%

Fundamentals of GODAVARI DRUGS LTD.

About GODAVARI DRUGS LTD.

Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. It offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. The company also provides loan license and contract manufacturing services. It serves the life science industry. The company was incorporated in 1987 and is based in Secunderabad, India.

Fundamental data was last updated by Penke on 2024-04-21 20:51:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of GODAVARI DRUGS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit GODAVARI DRUGS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare GODAVARI DRUGS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.4% means that ₹0.02 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GODAVARI DRUGS LTD.:

  • The MRQ is 2.4%. The company is making a profit. +1
  • The TTM is 2.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.4%0.0%
TTM2.4%YOY3.3%-0.9%
TTM2.4%5Y2.5%-0.1%
5Y2.5%10Y4.1%-1.6%
1.1.2. Return on Assets

Shows how efficient GODAVARI DRUGS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare GODAVARI DRUGS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • 3.1% Return on Assets means that GODAVARI DRUGS LTD. generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GODAVARI DRUGS LTD.:

  • The MRQ is 3.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.1%TTM3.1%0.0%
TTM3.1%YOY5.2%-2.1%
TTM3.1%5Y3.4%-0.2%
5Y3.4%10Y4.5%-1.1%
1.1.3. Return on Equity

Shows how efficient GODAVARI DRUGS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare GODAVARI DRUGS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • 11.3% Return on Equity means GODAVARI DRUGS LTD. generated ₹0.11 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GODAVARI DRUGS LTD.:

  • The MRQ is 11.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.3%TTM11.3%0.0%
TTM11.3%YOY17.7%-6.4%
TTM11.3%5Y12.5%-1.2%
5Y12.5%10Y13.2%-0.7%

1.2. Operating Efficiency of GODAVARI DRUGS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient GODAVARI DRUGS LTD. is operating .

  • Measures how much profit GODAVARI DRUGS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare GODAVARI DRUGS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GODAVARI DRUGS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.1%-2.1%
5Y2.1%10Y4.4%-2.3%
1.2.2. Operating Ratio

Measures how efficient GODAVARI DRUGS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.75 means that the operating costs are ₹1.75 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 1.752. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.752. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.752TTM1.7520.000
TTM1.752YOY1.750+0.002
TTM1.7525Y1.739+0.013
5Y1.73910Y1.694+0.045

1.3. Liquidity of GODAVARI DRUGS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if GODAVARI DRUGS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.18 means the company has ₹1.18 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 1.180. The company is just able to pay all its short-term debts.
  • The TTM is 1.180. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.180TTM1.1800.000
TTM1.180YOY1.287-0.107
TTM1.1805Y1.243-0.063
5Y1.24310Y1.370-0.127
1.3.2. Quick Ratio

Measures if GODAVARI DRUGS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare GODAVARI DRUGS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.83 means the company can pay off ₹0.83 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 0.828. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.828. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.828TTM0.8280.000
TTM0.828YOY1.002-0.174
TTM0.8285Y0.858-0.030
5Y0.85810Y0.833+0.025

1.4. Solvency of GODAVARI DRUGS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of GODAVARI DRUGS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare GODAVARI DRUGS LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.72 means that GODAVARI DRUGS LTD. assets are financed with 72.5% credit (debt) and the remaining percentage (100% - 72.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 0.725. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.725. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.725TTM0.7250.000
TTM0.725YOY0.708+0.017
TTM0.7255Y0.736-0.011
5Y0.73610Y0.683+0.053
1.4.2. Debt to Equity Ratio

Measures if GODAVARI DRUGS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare GODAVARI DRUGS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 263.4% means that company has ₹2.63 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GODAVARI DRUGS LTD.:

  • The MRQ is 2.634. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.634. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.634TTM2.6340.000
TTM2.634YOY2.422+0.211
TTM2.6345Y2.805-0.171
5Y2.80510Y2.393+0.412

2. Market Valuation of GODAVARI DRUGS LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings GODAVARI DRUGS LTD. generates.

  • Above 15 is considered overpriced but always compare GODAVARI DRUGS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 15.07 means the investor is paying ₹15.07 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GODAVARI DRUGS LTD.:

  • The EOD is 19.987. Based on the earnings, the company is fair priced.
  • The MRQ is 15.066. Based on the earnings, the company is fair priced.
  • The TTM is 15.066. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD19.987MRQ15.066+4.921
MRQ15.066TTM15.0660.000
TTM15.066YOY9.389+5.677
TTM15.0665Y10.209+4.857
5Y10.20910Y13.296-3.087
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GODAVARI DRUGS LTD.:

  • The EOD is 19.301. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 14.549. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 14.549. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD19.301MRQ14.549+4.752
MRQ14.549TTM14.5490.000
TTM14.549YOY8.229+6.319
TTM14.5495Y-15.182+29.730
5Y-15.18210Y-13.030-2.152
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of GODAVARI DRUGS LTD. is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of GODAVARI DRUGS LTD.:

  • The EOD is 2.264. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.707. Based on the equity, the company is underpriced. +1
  • The TTM is 1.707. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.264MRQ1.707+0.558
MRQ1.707TTM1.7070.000
TTM1.707YOY1.662+0.045
TTM1.7075Y1.226+0.481
5Y1.22610Y1.519-0.293
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of GODAVARI DRUGS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.0275.0270%6.965-28%4.347+16%3.375+49%
Book Value Per Share--44.37644.3760%39.349+13%33.451+33%26.054+70%
Current Ratio--1.1801.1800%1.287-8%1.243-5%1.370-14%
Debt To Asset Ratio--0.7250.7250%0.708+2%0.736-1%0.683+6%
Debt To Equity Ratio--2.6342.6340%2.422+9%2.805-6%2.393+10%
Dividend Per Share----0%-0%-0%0.000-100%
Eps--5.0275.0270%6.965-28%4.347+16%3.394+48%
Free Cash Flow Per Share--5.2065.2060%7.947-34%2.668+95%-0.144+103%
Free Cash Flow To Equity Per Share--0.1990.1990%0.483-59%-0.090+145%-0.063+132%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--126.731--------
Intrinsic Value_10Y_min--20.146--------
Intrinsic Value_1Y_max--6.071--------
Intrinsic Value_1Y_min--0.405--------
Intrinsic Value_3Y_max--23.293--------
Intrinsic Value_3Y_min--2.623--------
Intrinsic Value_5Y_max--46.605--------
Intrinsic Value_5Y_min--6.362--------
Market Cap756664640.000+25%570360070.000570360070.0000%492494700.000+16%332456514.000+72%295474228.500+93%
Net Profit Margin--0.0240.0240%0.033-27%0.025-5%0.041-42%
Operating Margin----0%-0%0.021-100%0.044-100%
Operating Ratio--1.7521.7520%1.750+0%1.739+1%1.694+3%
Pb Ratio2.264+25%1.7071.7070%1.662+3%1.226+39%1.519+12%
Pe Ratio19.987+25%15.06615.0660%9.389+60%10.209+48%13.296+13%
Price Per Share100.480+25%75.74075.7400%65.400+16%44.148+72%39.237+93%
Price To Free Cash Flow Ratio19.301+25%14.54914.5490%8.229+77%-15.182+204%-13.030+190%
Price To Total Gains Ratio19.987+25%15.06615.0660%9.389+60%10.209+48%13.340+13%
Quick Ratio--0.8280.8280%1.002-17%0.858-3%0.833-1%
Return On Assets--0.0310.0310%0.052-40%0.034-7%0.045-30%
Return On Equity--0.1130.1130%0.177-36%0.125-9%0.132-14%
Total Gains Per Share--5.0275.0270%6.965-28%4.347+16%3.375+49%
Usd Book Value--4010064.0004010064.0000%3555768.000+13%3022801.824+33%2354356.064+70%
Usd Book Value Change Per Share--0.0600.0600%0.084-28%0.052+16%0.041+49%
Usd Book Value Per Share--0.5330.5330%0.472+13%0.401+33%0.313+70%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps--0.0600.0600%0.084-28%0.052+16%0.041+48%
Usd Free Cash Flow--470448.000470448.0000%718164.000-34%241060.800+95%-13015.568+103%
Usd Free Cash Flow Per Share--0.0620.0620%0.095-34%0.032+95%-0.002+103%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%0.006-59%-0.001+145%-0.001+132%
Usd Market Cap9079975.680+25%6844320.8406844320.8400%5909936.400+16%3989478.168+72%3545690.742+93%
Usd Price Per Share1.206+25%0.9090.9090%0.785+16%0.530+72%0.471+93%
Usd Profit--454296.000454296.0000%629436.000-28%392841.504+16%306678.618+48%
Usd Revenue--19154976.00019154976.0000%19332746.400-1%14943433.848+28%10874370.659+76%
Usd Total Gains Per Share--0.0600.0600%0.084-28%0.052+16%0.041+49%
 EOD+4 -4MRQTTM+0 -0YOY+7 -255Y+22 -1110Y+20 -15

3.2. Fundamental Score

Let's check the fundamental score of GODAVARI DRUGS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.987
Price to Book Ratio (EOD)Between0-12.264
Net Profit Margin (MRQ)Greater than00.024
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.828
Current Ratio (MRQ)Greater than11.180
Debt to Asset Ratio (MRQ)Less than10.725
Debt to Equity Ratio (MRQ)Less than12.634
Return on Equity (MRQ)Greater than0.150.113
Return on Assets (MRQ)Greater than0.050.031
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of GODAVARI DRUGS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.790
Ma 20Greater thanMa 5098.582
Ma 50Greater thanMa 10098.776
Ma 100Greater thanMa 20098.659
OpenGreater thanClose101.820
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,214,330
Total Liabilities880,158
Total Stockholder Equity334,172
 As reported
Total Liabilities 880,158
Total Stockholder Equity+ 334,172
Total Assets = 1,214,330

Assets

Total Assets1,214,330
Total Current Assets870,057
Long-term Assets344,272
Total Current Assets
Cash And Cash Equivalents 30,846
Net Receivables 579,349
Inventory 198,557
Other Current Assets 52,430
Total Current Assets  (as reported)870,057
Total Current Assets  (calculated)861,182
+/- 8,875
Long-term Assets
Property Plant Equipment 339,853
Other Assets 4,419
Long-term Assets  (as reported)344,272
Long-term Assets  (calculated)344,272
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities737,082
Long-term Liabilities239,089
Total Stockholder Equity334,172
Total Current Liabilities
Short-term Debt 56,859
Short Long Term Debt 119,475
Accounts payable 461,486
Total Current Liabilities  (as reported)737,082
Total Current Liabilities  (calculated)637,820
+/- 99,262
Long-term Liabilities
Long term Debt Total 119,475
Long term Debt 116,584
Capital Lease Obligations Min Short Term Debt-56,859
Long-term Liabilities Other 37,859
Long-term Liabilities  (as reported)239,089
Long-term Liabilities  (calculated)217,059
+/- 22,030
Total Stockholder Equity
Common Stock75,305
Retained Earnings 258,867
Total Stockholder Equity (as reported)334,172
Total Stockholder Equity (calculated)334,172
+/-0
Other
Capital Stock75,305
Cash And Equivalents30,846
Cash and Short Term Investments 30,846
Common Stock Shares Outstanding 7,531
Liabilities and Stockholders Equity 1,214,330
Net Debt 304,117
Net Invested Capital 669,135
Net Working Capital 228,989
Property Plant and Equipment Gross 339,853



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
> Total Assets 
150,000
152,491
347,408
505,446
557,003
630,236
746,486
839,161
911,398
1,014,110
1,214,330
1,214,3301,014,110911,398839,161746,486630,236557,003505,446347,408152,491150,000
   > Total Current Assets 
73,000
64,681
268,609
403,970
426,285
472,890
564,946
608,274
676,135
743,342
870,057
870,057743,342676,135608,274564,946472,890426,285403,970268,60964,68173,000
       Cash And Cash Equivalents 
3,000
2,515
2,634
6,504
8,828
16,163
15,259
14,266
16,383
29
30,846
30,8462916,38314,26615,25916,1638,8286,5042,6342,5153,000
       Net Receivables 
25,000
20,927
154,072
245,463
284,823
274,301
347,134
369,335
451,211
555,790
579,349
579,349555,790451,211369,335347,134274,301284,823245,463154,07220,92725,000
       Inventory 
31,000
30,368
92,803
107,449
113,242
134,687
164,679
177,520
146,500
100,337
198,557
198,557100,337146,500177,520164,679134,687113,242107,44992,80330,36831,000
       Other Current Assets 
14,000
10,277
18,383
176
18,585
47,739
37,874
47,153
56,367
58,364
52,430
52,43058,36456,36747,15337,87447,73918,58517618,38310,27714,000
   > Long-term Assets 
0
0
0
0
130,718
157,346
172,435
230,887
235,264
271,073
344,272
344,272271,073235,264230,887172,435157,346130,7180000
       Property Plant Equipment 
0
78,944
76,931
99,228
128,850
155,218
170,163
227,431
231,924
267,411
339,853
339,853267,411231,924227,431170,163155,218128,85099,22876,93178,9440
       Long Term Investments 
0
1
1
1
1
1
1
0
0
0
0
00001111110
       Other Assets 
0
8,865
1,867
2,247
1,867
2,127
2,271
3,456
3,338
3,356
4,419
4,4193,3563,3383,4562,2712,1271,8672,2471,8678,8650
> Total Liabilities 
70,000
57,406
216,816
361,344
394,808
459,748
563,913
636,581
667,537
717,796
880,158
880,158717,796667,537636,581563,913459,748394,808361,344216,81657,40670,000
   > Total Current Liabilities 
40,000
31,091
171,074
310,726
334,995
374,081
462,184
512,487
505,120
577,610
737,082
737,082577,610505,120512,487462,184374,081334,995310,726171,07431,09140,000
       Short-term Debt 
24,000
24,168
84,822
115,587
113,335
115,372
130,016
149,117
135,887
85,612
56,859
56,85985,612135,887149,117130,016115,372113,335115,58784,82224,16824,000
       Short Long Term Debt 
24,000
24,168
84,822
155,113
117,314
115,372
140,450
164,356
135,887
112,903
119,475
119,475112,903135,887164,356140,450115,372117,314155,11384,82224,16824,000
       Accounts payable 
6,000
5,604
87,794
173,567
200,597
230,210
303,629
302,729
295,048
433,169
461,486
461,486433,169295,048302,729303,629230,210200,597173,56787,7945,6046,000
       Other Current Liabilities 
26,000
23,949
27,869
13,731
13,827
13,183
12,759
40,210
14,773
3,189
0
03,18914,77340,21012,75913,18313,82713,73127,86923,94926,000
   > Long-term Liabilities 
0
0
0
0
59,812
85,012
101,729
124,094
162,417
140,187
239,089
239,089140,187162,417124,094101,72985,01259,8120000
       Long term Debt Total 
0
0
0
39,174
43,857
65,996
80,121
111,636
144,898
117,821
119,475
119,475117,821144,898111,63680,12165,99643,85739,174000
       Capital Lease Obligations 
0
0
0
0
394
441
0
0
0
0
0
000004413940000
       Other Liabilities 
0
2,148
9,315
11,444
15,955
19,671
12,503
12,458
0
0
0
00012,45812,50319,67115,95511,4449,3152,1480
> Total Stockholder Equity
0
95,085
130,592
144,102
162,195
170,488
182,573
202,581
243,861
296,314
334,172
334,172296,314243,861202,581182,573170,488162,195144,102130,59295,0850
   Common Stock
182,000
75,305
75,305
75,305
75,305
75,305
75,305
75,305
75,305
75,305
75,305
75,30575,30575,30575,30575,30575,30575,30575,30575,30575,305182,000
   Retained Earnings 
-109,000
-93,693
-58,186
68,797
-24,929
-16,636
-4,551
15,457
168,556
221,009
258,867
258,867221,009168,55615,457-4,551-16,636-24,92968,797-58,186-93,693-109,000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
7,154
7,154
7,154
5,500
5,500
5,500
5,500
0
0
0
0005,5005,5005,5005,5007,1547,1547,1540



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue1,596,248
Cost of Revenue-1,280,577
Gross Profit315,671315,671
 
Operating Income (+$)
Gross Profit315,671
Operating Expense-1,516,476
Operating Income82,068-1,200,805
 
Operating Expense (+$)
Research Development2,817
Selling General Administrative49,591
Selling And Marketing Expenses0
Operating Expense1,516,47652,408
 
Net Interest Income (+$)
Interest Income27,373
Interest Expense-39,273
Other Finance Cost-27,373
Net Interest Income-39,273
 
Pretax Income (+$)
Operating Income82,068
Net Interest Income-39,273
Other Non-Operating Income Expenses0
Income Before Tax (EBT)49,34782,068
EBIT - interestExpense = -39,273
37,858
77,131
Interest Expense39,273
Earnings Before Interest and Taxes (EBIT)088,620
Earnings Before Interest and Taxes (EBITDA)108,055
 
After tax Income (+$)
Income Before Tax49,347
Tax Provision-11,489
Net Income From Continuing Ops37,85837,858
Net Income37,858
Net Income Applicable To Common Shares37,858
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net039,273
 

Technical Analysis of GODAVARI DRUGS LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of GODAVARI DRUGS LTD.. The general trend of GODAVARI DRUGS LTD. is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine GODAVARI DRUGS LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GODAVARI DRUGS LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 108.15 < 114.00 < 114.00.

The bearish price targets are: 94.50 > 90.10 > 90.00.

Tweet this
GODAVARI DRUGS LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GODAVARI DRUGS LTD.. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GODAVARI DRUGS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GODAVARI DRUGS LTD.. The current macd is 0.42462981.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the GODAVARI DRUGS LTD. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for GODAVARI DRUGS LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the GODAVARI DRUGS LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
GODAVARI DRUGS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartGODAVARI DRUGS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GODAVARI DRUGS LTD.. The current adx is 27.18.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy GODAVARI DRUGS LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
GODAVARI DRUGS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GODAVARI DRUGS LTD.. The current sar is 94.55.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
GODAVARI DRUGS LTD. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GODAVARI DRUGS LTD.. The current rsi is 55.79. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
GODAVARI DRUGS LTD. Daily Relative Strength Index (RSI) ChartGODAVARI DRUGS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GODAVARI DRUGS LTD.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the GODAVARI DRUGS LTD. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
GODAVARI DRUGS LTD. Daily Stochastic Oscillator ChartGODAVARI DRUGS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GODAVARI DRUGS LTD.. The current cci is 40.86.

GODAVARI DRUGS LTD. Daily Commodity Channel Index (CCI) ChartGODAVARI DRUGS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GODAVARI DRUGS LTD.. The current cmo is 18.13.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
GODAVARI DRUGS LTD. Daily Chande Momentum Oscillator (CMO) ChartGODAVARI DRUGS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GODAVARI DRUGS LTD.. The current willr is -43.04761905.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that GODAVARI DRUGS LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
GODAVARI DRUGS LTD. Daily Williams %R ChartGODAVARI DRUGS LTD. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GODAVARI DRUGS LTD..

GODAVARI DRUGS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GODAVARI DRUGS LTD.. The current atr is 4.41951071.

GODAVARI DRUGS LTD. Daily Average True Range (ATR) ChartGODAVARI DRUGS LTD. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GODAVARI DRUGS LTD.. The current obv is 2,479,331.

GODAVARI DRUGS LTD. Daily On-Balance Volume (OBV) ChartGODAVARI DRUGS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GODAVARI DRUGS LTD.. The current mfi is 40.01.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
GODAVARI DRUGS LTD. Daily Money Flow Index (MFI) ChartGODAVARI DRUGS LTD. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GODAVARI DRUGS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

GODAVARI DRUGS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GODAVARI DRUGS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.790
Ma 20Greater thanMa 5098.582
Ma 50Greater thanMa 10098.776
Ma 100Greater thanMa 20098.659
OpenGreater thanClose101.820
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of GODAVARI DRUGS LTD. with someone you think should read this too:
  • Are you bullish or bearish on GODAVARI DRUGS LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about GODAVARI DRUGS LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GODAVARI DRUGS LTD.

I send you an email if I find something interesting about GODAVARI DRUGS LTD..


Comments

How you think about this?

Leave a comment

Stay informed about GODAVARI DRUGS LTD..

Receive notifications about GODAVARI DRUGS LTD. in your mailbox!